oppenheimer - Search News

Alumis draws Outperform at Oppenheimer

Alumis draws Outperform at Oppenheimer on valuation disconnect

Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation and a 12–18-month price target of $32 on Thursday, noting that despite the potential in its pipeline, the company continues to trade near its cash level.

Business Insider · 18h

Alumis initiated with an Outperform at Oppenheimer

Oppenheimer initiated coverage of Alumis (ALMS) with an Outperform rating and $32 price target The company is focused on delivering

Fintel on MSN · 6h

Oppenheimer Initiates Coverage of Alumis (ALMS) with Outperform Recommendation

Fintel reports that on January 30, 2025, Oppenheimer initiated coverage of Alumis (NasdaqGS:ALMS) with a Outperform recommendation. Analyst Price Forecast Suggests 356.72% Upside As of January 29, 2025,

Hosted on MSN · 17h

Oppenheimer sets Alumis stock with Outperform, $32 target

Oppenheimer initiated coverage on Alumis Inc (NASDAQ:ALMS) with an Outperform rating and a price target of $32.00. The firm's analysts highlighted the biopharmaceutical company's focus on developing oral solutions for inflammatory and autoimmune disorders.

Christopher Nolan, Odyssey and Oppenheimer

GamesRadar on MSN · 18h

Another Oppenheimer actor is reuniting with Christopher Nolan for his next movie as filming begins next month

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The Hollywood Reporter.

The News International · 15h

‘Oppenheimer’ star to join Christopher Nolan’s ‘Odyssey’ adaptation

Christopher Nolan has recently announced his reunion with Oppenheimer star Benny Safdie for his next movie.Safdie, who appeared as physicist Edward Teller in Nolan’s Oscar-winning movie,

Hosted on MSN · 13h

Christopher Nolan’s The Odyssey: Everything We Know So Far

In the wake of Oppenheimer, Christopher Nolan could do basically anything. His choice: go full Homer (no, not ‘The Simpsons Movie 2’) with an adaptation of epic Greek poem The Odyssey. It should add a new quiver to the legendary director’s bow – his first swords-and-sandals epic,

18hon MSN

Trump's Mass Deportation Plans Attacked in Home State Newspaper: 'Insane'

Andres Oppenheimer, a columnist for the "Miami Herald," said the Trump administration is targeting illegal immigrants with ...

3don MSN

‘Wonka,’ ‘Dune 2,’ ‘Oppenheimer’ Drive U.K. Home Entertainment to Record $6.4 Billion Year

British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...

cryptopolitan on MSN1d

Oppenheimer downgrades Apple, cites weakening iPhone sales and AI innovation worries

Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.

Ovid Therapeutics upgraded at Oppenheimer as OV329’s promise ‘quite real’

Oppenheimer upgraded Ovid Therapeutics (OVID) to Outperform from Perform with a $4 price target The firm says OV329’s promise is “quite real” ...

4don MSN

Oscar Nominee Joshua Oppenheimer Worries His ‘Home Country Is Becoming a Dictatorship' But It's Not ‘The End' Just Yet: ‘Above You, There's Still a Sky'

U.S. filmmaker Joshua Oppenheimer, now based in Denmark, worries his "home country is perhaps becoming a dictatorship." "It ...

Jewish Telegraphic Agency2d

The Jewish story behind ‘Oppenheimer,’ explained

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Card Collecting Reaches Absurd New Heights As J. Robert Oppenheimer (Yes, That One) Now Has A Rookie Card: Reactions

The card collecting industry has exploded in recent years to such an extent that industry leader Topps is now producing a Robert Oppenheimer card that's ...

Did Cillian Murphy Skip On All ‘Oppenheimer’ Cast Dinners?

Cillian Murphy’s dedication to playing J. Robert Oppenheimer in Oppenheimer went so deep, it literally left his brain “too ...

10hon MSN

Why Alumis (ALMS) Stock Is Advancing Today

Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Alumis draws Outperform at Oppenheimer

Christopher Nolan, Odyssey and Oppenheimer

Related topics